Does C-reactive protein predict time to recovery and benefit from oseltamivir treatment in primary care patients with influenza-like illness? A randomized controlled trial secondary analysis

• Main Authors: Nicolay Jonassen Harbin (Author), Karin Rystedt (Author), Morten Lindbaek (Author), Ruta Radzeviciene (Author), Johan Westin (Author), Ronny Gunnarsson (Author), Christopher C. Butler (Author), Alike W. van der Velden (Author), Theo J. Verheij (Author), Pär-Daniel Sundvall (Author)
• Format: Book
• Published: Taylor & Francis Group, 2021-10-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Objective Recovery time and treatment effect of oseltamivir in influenza-like illness (ILI) differs between patient groups. A point-of-care test to better predict ILI duration and identify patients who are most likely to benefit from oseltamivir treatment would aid prescribing decisions in primary c...